Amneal Oncology Private Limited, a active private limited company, was established on 10 November 1998 in Ahmedabad, Gujarat, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24230GJ1998PTC084755. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹35.00 Cr and a paid-up capital of ₹33.65 Cr.
Formerly known as Epsilon Pharmaceuticals Private Limited. It upholds a compliant status. Employing 262 professional, Its leadership includes Rajeev Midha (Director), Suresh Punambhai Patel (Director), Rahul Maitra (Director). Past directors included Rajeev Midha, Nikunj Bansibhai Patel, Sanjay Kumar Jain. It holds no open charges and ₹58.32 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 901-911 Iscon Elegance, Opp. Karnavati Club, S.G.Highway,, Ahmedabad, Gujarat, 380015.
U24230GJ1998PTC084755
084755
10 November 1998
₹35.00 Cr
₹33.65 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Amneal Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Midha | Director | 25 Jan 2019 | Current |
| Suresh Punambhai Patel | Director | 01 Dec 2014 | Current |
| Rahul Maitra | Director | 14 May 2024 | Current |
| Sandeep Radhakisan Raktate | Director | 14 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 25 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 27 Dec 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 02 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amneal Oncology Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.36% decrease. The company also saw a substantial improvement in profitability, with a 28.81% increase in profit. The company's net worth moved up by a moderate rise of 7.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Amneal Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹583,190,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2011 | Vijaya Bank (Lead Bank) | ₹58.21 Cr | Satisfied |
| 24 Feb 2011 | Vijaya Bank | ₹1.09 M | Satisfied |
Explore comprehensive loan charge details -
Amneal Oncology has a workforce of 262 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Amneal Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amneal Oncology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Amneal Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Rahul Maitra was appointed as a Director was appointed as a Director on 14 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Progress on Sandeep Radhakisan Raktate was appointed as a Director was appointed as a Director on 14 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Progress on Amneal Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Ekta Kailash Joshi was appointed as a Company Secretary was appointed as a Company Secretary on 07 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Rajeev Midha was appointed as a Director was appointed as a Director on 25 Jan 2019 & has been associated with this company since 6 years 10 months . was completed.
Dr. Reddy’s could steal a march over Amneal by launching the first generic version of the female contraceptive in the U.S..
The CIN of Amneal Oncology Private Limited is U24230GJ1998PTC084755.
Amneal Oncology Private Limited is headquartered at 901-911 Iscon Elegance, Opp. Karnavati Club, S.G.Highway,, Ahmedabad, Gujarat, 380015.
Amneal Oncology Private Limited was incorporated on 10 November 1998.
The current directors of Amneal Oncology Private Limited are
The primary industry of Amneal Oncology Private Limited is Manufacturing.
Amneal Oncology Private Limited is unlisted.
The authorized capital of Amneal Oncology Private Limited is ₹35.00 Cr, and the paid-up capital is ₹33.65 Cr.
The compliance status of Amneal Oncology Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX